Epigenetic biomarkers in skin cancer

被引：48
|
作者：
Greenberg, Edward S. [1 ]
Chong, Kelly K. [1 ]
Huynh, Kelly T. [1 ]
Tanaka, Ryo [1 ]
Hoon, Dave S. B. [1 ]
机构：
[1] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA
来源：
CANCER LETTERS | 2014年 / 342卷 / 02期
基金：
美国国家卫生研究院;
关键词：
Epigenetics; Biomarker; Methylation; MicroRNA; Melanoma; Prognosis; ISLAND METHYLATOR PHENOTYPE; MELANOMA-CELL PROLIFERATION; ABERRANT DNA METHYLATION; TUMOR-SUPPRESSOR GENES; REAL-TIME PCR; DOWN-REGULATION; CUTANEOUS MELANOMA; PROMOTER HYPERMETHYLATION; CIRCULATING MICRORNAS; PERIPHERAL-BLOOD;
D O I：
10.1016/j.canlet.2012.01.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Epigenetic aberrations have been associated with cutaneous melanoma tumorigenesis and progression including dysregulated DNA gene promoter region methylation, histone modification, and microRNA. Several of these major epigenetic aberrations have been developed into biomarkers. Epigenetic biomarkers can be detected in tissue and in blood as circulating DNA in melanoma patients. There is strong evidence that biomarkers in cutaneous melanoma will have an important role as companions to therapeutics and overall patient management. Important progress has been made in epigenetic melanoma biomarker development and verification of clinical utility, and this review discusses some of the key current developments and existing challenges. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：170 / 177
页数：8
相关论文
共 50 条
  • [21] Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer
    Kumaraswamy, Anbarasu
    Leng, Katherine R. Welker
    Westbrook, Thomas C.
    Yates, Joel A.
    Zhao, Shuang G.
    Evans, Christopher P.
    Feng, Felix Y.
    Morgan, Todd M.
    Alumkal, Joshi J.
    EUROPEAN UROLOGY, 2021, 80 (01) : 71 - 81
  • [22] Epigenetic Cancer Prevention Mechanisms in Skin Cancer
    Kamalika Saha
    Thomas J. Hornyak
    Richard L. Eckert
    The AAPS Journal, 2013, 15 : 1064 - 1071
  • [23] Epigenetic Cancer Prevention Mechanisms in Skin Cancer
    Saha, Kamalika
    Hornyak, Thomas J.
    Eckert, Richard L.
    AAPS JOURNAL, 2013, 15 (04): : 1064 - 1071
  • [24] Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration
    Oh, Chang Kyo
    Cho, Young-Seok
    INTESTINAL RESEARCH, 2024, 22 (02) : 131 - 151
  • [25] Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
    Monika Bauden
    Dorian Pamart
    Daniel Ansari
    Marielle Herzog
    Mark Eccleston
    Jake Micallef
    Bodil Andersson
    Roland Andersson
    Clinical Epigenetics, 2015, 7
  • [26] Research progress and applications of epigenetic biomarkers in cancer
    Gao, Jianjun
    Shi, Wujiang
    Wang, Jiangang
    Guan, Canghai
    Dong, Qingfu
    Sheng, Jialin
    Zou, Xinlei
    Xu, Zhaoqiang
    Ge, Yifei
    Yang, Chengru
    Li, Jiehan
    Bao, Haolin
    Zhong, Xiangyu
    Cui, Yunfu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Epigenetic biomarkers for human cancer: The time is now
    Mulero-Navarro, Sonia
    Esteller, Manel
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (01) : 1 - 11
  • [28] Potential Epigenetic Biomarkers for Prostate Cancer Screening
    Bae, Jong-Myon
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2018, 22 (02) : 142 - 144
  • [29] Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
    Berg, Marianne
    Soreide, Kjetil
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (12) : 9426 - 9439
  • [30] Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
    Bauden, Monika
    Pamart, Dorian
    Ansari, Daniel
    Herzog, Marielle
    Eccleston, Mark
    Micallef, Jake
    Andersson, Bodil
    Andersson, Roland
    CLINICAL EPIGENETICS, 2015, 7
12345